切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2017, Vol. 13 ›› Issue (04) : 490 -492. doi: 10.3877/cma.j.issn.1673-5250.2017.04.022

所属专题: 文献

综述

缺氧诱导因子-1α及可溶性血管内皮生长因子受体-1预测子痫前期的意义
单委1, 吴雅娟1, 蒋敏1   
  1. 1. 225001 江苏,扬州大学临床医学院妇产科
  • 收稿日期:2017-05-19 修回日期:2017-07-10 出版日期:2017-08-01

Significance of hypoxia inducible factor-1α and soluble fms-like tyrosine kinase receptor-1 in the prediction of preeclampsia

Wei Shan1, Yajuan Wu1, Min Jiang1   

  1. 1. Department of Obstetrics and Gynecology, Clinical Medical School, Yangzhou University, Yangzhou 225001, Jiangsu Province, China
  • Received:2017-05-19 Revised:2017-07-10 Published:2017-08-01
  • About author:
    Corresponding author: Lu Dan, Email:
引用本文:

单委, 吴雅娟, 蒋敏. 缺氧诱导因子-1α及可溶性血管内皮生长因子受体-1预测子痫前期的意义[J]. 中华妇幼临床医学杂志(电子版), 2017, 13(04): 490-492.

Wei Shan, Yajuan Wu, Min Jiang. Significance of hypoxia inducible factor-1α and soluble fms-like tyrosine kinase receptor-1 in the prediction of preeclampsia[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2017, 13(04): 490-492.

子痫前期(PE)是导致围生期母婴死亡的主要原因之一,其发病机制目前尚不明确。近年研究表明,缺氧诱导因子(HIF)-1α及可溶性血管内皮生长因子受体(sFlt)-1,是导致及加重PE症状的2个重要因子。在PE患者外周血及胎盘组织中,HIF-1α表达增多,可促使靶基因sFlt-1表达增多,从而促进并加重孕妇血管损伤、各脏器功能障碍及母婴并发症的发生。根据HIF-1α及sFlt-1的生物学功能及其在PE患者外周血及胎盘组织中的表达水平,可作为预测PE发生、孕产妇并发症发生情况及围生儿预后的指标之一,为PE的早期预防、早期治疗,以及降低母儿并发症及死亡率,提供新的理论依据和途径。

Preeclampsia (PE) is one of the main causes of maternal and infant death, but its pathogenesis has not been fully clarified. Recent studies have indicated that hypoxia inducible factor(HIF)-1α and soluble fms-like tyrosine kinase receptor (sFlt)-1 are the two important factors leading to and aggravating the symptoms of PE. With the expression of HIF-1α in peripheral blood and placenta tissue of PE patients increased, it would prompted the increased expression of target gene sFlt-1, which led to maternal vascular injury and organ dysfunction, and maternal and neonatal complications occur. According to the biological function of HIF-1α and sFlt-1, and their expression levels in peripheral blood and placenta tissue of PE patients, it can be one of the prediction indicators of the occurrence of PE, maternal complications and prognosis of perineonate for early prevention and treatment, and provide a theoretical basis and a new way to reduce maternal and neonatal complications and mortality.

[1]
谢幸,苟文丽. 妇产科学.8版[M]. 北京:人民卫生出版社,2013: 64-71.
[2]
刘静芳,刘国莉,王建六. 预测子痫前期发病相关因素的研究进展[J]. 现代妇产科进展,2013, 22(2): 159-162.
[3]
林其德,段涛,孔北华,等. 子痫前期-子痫相关问题的讨论[J]. 现代妇产科进展,2006, 15(9): 641-653.
[4]
Sun L, Liu Y, Lin S, et al. Early growth response gene-1 and hypoxia-inducible factor-1α affect tumor metastasis via regulation of tissue factor[J]. Acta Oncol, 2013, 52(4): 842-851.
[5]
Herraiz I, Simón E, Gómez-Arriaga P, et al. Angiogenesis-related biomarkers (sFlt-1/PLGF) in the prediction and diagnosis of placental dysfunction: an approach for clinical integration[J]. Int J Mol Sci, 2015, 16(8): 19009-19026.
[6]
Chang SD, Chao AS, Peng HH, et al. Analyses of placental gene expression in pregnancy-related hypertensive disorders[J]. Taiwan J Obstet Gynecol, 2011, 50(3): 283-291.
[7]
Zezza L, Ralli E, Conti E, et al. Hypertension in pregnancy: the most recent findings in pathophysiology, diagnosis and therapy[J]. Minerva Ginecol, 2014, 66(1): 103-126.
[8]
Hawfield A, Freedman BI. Pre-eclampsia: the pivotal role of the placenta in its pathophysiology and markers for early detection[J]. Ther Adv Cardiovasc Dis, 2009, 3(1): 65-73.
[9]
Naicker T, Dorsamy E, Ramsuran D, et al. The role of apoptosis on trophoblast cell invasion in the placental bed of normotensive and preeclamptic pregnancies[J]. Hypertens Pregnancy, 2013, 32(3): 245-256.
[10]
彭文,王燕芸,贾颐舫. 子痫前期患者胎盘组织及外周血PLGF和sFlt-1的表达及作用机制[J]. 中国妇幼保健,2015, 30(26): 4559-4561.
[11]
Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation[J]. Mol Cell Biol, 1992, 12(12): 5447-5454.
[12]
Yamamoto Y, Ibusuki M, Okumura Y, et al. Hypoxia-inducible factor 1alpha is closely linked to an aggressive phenotype in breast cancer[J]. Breast Cancer Res Treat, 2008, 110(3): 465-475.
[13]
Wang GP, Zhang H, Zhang ZF, et al. Clinical and pathological characteristics of intraductal proliferative lesions and coexist with invasive ductal carcinomas[J]. Chinese-German J Clin Oncol, 2013, 12(12): 574-580.
[14]
Palmer KR, Kaitu′u-Lino TJ, Hastie R, et al. Placental-specific sFLT-1 e15a protein is increased in preeclampsia, antagonizes vascular endothelial growth factor signaling, and has antiangiogenic activity[J]. Hypertension, 2015, 66(6): 1251-1259.
[15]
Tsatsaris V, Goffin F, Munaut C, et al. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences[J]. J Clin Endocrinol Metab, 2003, 88(11): 5555-5563.
[16]
Henao DE, Cadavid AP, Saleem MA. Exogenous vascular endothelial growth factor supplementation can restore the podocyte barrier-forming capacity disrupted by sera of preeclamptic women[J]. J Obstet Gynaecol Res, 2013, 39(1): 46-52.
[17]
Chedraui P, Lockwood CJ, Schatz F, et al. Increased plasma soluble fms-like tyrosine kinase 1 and endoglin levels in pregnancies complicated with preeclampsia[J]. J Matern Fetal Neonatal Med, 2009, 22(7): 565-570.
[18]
Ahamad S, Hewett PW, Al-Ani B, et al. Autocrine activity of soluble Flt-1 controls endothelial cell function and angiogenesis[J]. Vasc Cell, 2011, 3(1): 15.
[19]
Sezer SD, Küçük M, Döger FK, et al. VEGF, PIGF and HIF-1α in placentas of early- and late-onset pre-eclamptic patients[J]. Gynecol Endocrinol, 2013, 29(8): 797-800.
[20]
Akhilesh M, Mahalingam V, Nalliah S, et al. Hypoxia-inducible factor-1α as a predictive marker in pre-eclampsia[J]. Biomed Rep, 2013, 1(2): 257-258.
[21]
鲁晓燕,刘曼华,赵枰,等. 孕妇血清缺氧诱导因子1α水平与子痫前期病理特点的关系[J]. 山东医药,2013, 53(38): 64-65.
[22]
Giguère Y, Charland M, Bujold E, et al. Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review[J]. Ann Biol Clin (Paris), 2011, 69(3): 257-271.
[23]
冯敏,杨海澜,王海燕,等. 血清及尿液中sFlt-1/PLGF比值的变化与子痫前期相关性研究[J]. 中国妇幼保健,2011, 26(6): 829-831.
[24]
陶娅玲,漆洪波. 子痫前期孕妇血清及尿液中VEGF、PLGF、sFlt-1水平变化及意义[J]. 实用妇产科杂志,2008, 24(8): 496-498.
[25]
Rana S, Karumanchi SA, Levine RJ, et al. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia[J]. Hypertension, 2007, 50(1): 137-142.
[26]
Baltajian K, Hecht JL, Wenger JB, et al. Placental lesions of vascular insufficiency are associated with anti-angiogenic state in women with preeclampsia[J]. Hypertens Pregnancy, 2014, 33(4): 427-439.
[1] 马敏榕, 李聪, 周勤. 宫颈癌治疗研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 497-504.
[2] 林昌盛, 战军, 肖雪. 上皮性卵巢癌患者诊疗中基因检测及分子靶向药物治疗[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 505-510.
[3] 顾娟, 孙擎擎, 胡方方, 曹义娟, 祁玉娟. 子宫内膜容受性检测改善胚胎反复种植失败患者妊娠结局的临床应用[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 582-587.
[4] 韩春颖, 王婷婷, 李艳艳, 朴金霞. 子宫内膜癌患者淋巴管间隙浸润预测因素研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 403-409.
[5] 陈荟竹, 郭应坤, 汪昕蓉, 宁刚, 陈锡建. 上皮性卵巢癌"二元论模型"的分子生物学研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 394-402.
[6] 周东杰, 蒋敏, 范海瑞, 高玲玲, 孔祥, 卢丹, 王丽萍. 非编码RNA在卵泡发育成熟中作用及其机制的研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 387-393.
[7] 魏权, 张燊, 陈慧佳, 邹姮, 胡丽娜. 女性生殖道微生物群与辅助生殖技术相关性研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(02): 151-155.
[8] 刘艳艳, 谭曦, 彭雪. 妊娠合并膀胱低度恶性潜能乳头状尿路上皮肿瘤并文献复习[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(02): 212-218.
[9] 胡欧婵, 黄仲英. 不明原因复发性流产患者的治疗研究现状与展望[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(01): 16-22.
[10] 尤琳, 蔡振伟, 乔荆. Turner综合征临床研究现状[J]. 中华妇幼临床医学杂志(电子版), 2022, 18(06): 634-639.
[11] 张晓芳, 王平. 阴道黑色素瘤诊疗研究现状[J]. 中华妇幼临床医学杂志(电子版), 2022, 18(06): 621-626.
[12] 孙环蕊, 张若鹏. 复发性流产与肠道微生物群失衡[J]. 中华妇幼临床医学杂志(电子版), 2022, 18(05): 506-511.
[13] 陈雨婷, 杨烨, 谢奇君, 凌秀凤. 女性不孕不育相关疾病患者的生殖道微生物组成异常研究现状[J]. 中华妇幼临床医学杂志(电子版), 2022, 18(05): 615-620.
[14] 江振剑, 蒋明, 黄大莉. 基于决策曲线分析血清E-cad、HIF-1α预测乳腺癌改良根治术治疗预后的临床研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(03): 272-275.
[15] 吴晓翔, 杨波, 李景漩, 张凤玲, 郭桂辉, 郑少培. 脐动脉超声检查联合NLR、sFlt-1/PLGF对妊娠高血压综合征患者不良妊娠结局的预测价值[J]. 中华临床医师杂志(电子版), 2023, 17(03): 266-271.
阅读次数
全文


摘要